Zacks Investment Research lowered shares of HMS (NASDAQ:HMSY) from a hold rating to a sell rating in a research report report published on Saturday.
According to Zacks, “HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and member engagement solutions to help customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers. “
HMSY has been the topic of a number of other reports. Citigroup initiated coverage on HMS in a report on Thursday, January 4th. They issued a neutral rating on the stock. Canaccord Genuity reaffirmed a buy rating and issued a $22.00 target price on shares of HMS in a report on Monday, October 30th. BidaskClub raised HMS from a sell rating to a hold rating in a report on Wednesday, December 20th. Cantor Fitzgerald cut HMS from an overweight rating to a neutral rating in a report on Monday, November 20th. Finally, Robert W. Baird reaffirmed a buy rating on shares of HMS in a report on Sunday, November 19th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, four have assigned a buy rating and two have given a strong buy rating to the stock. The stock has a consensus rating of Buy and an average target price of $20.39.
HMS (HMSY) opened at $15.63 on Friday. HMS has a twelve month low of $11.01 and a twelve month high of $20.90. The company has a market capitalization of $1,314.23, a price-to-earnings ratio of 30.06, a P/E/G ratio of 2.30 and a beta of 0.84.
HMS announced that its board has approved a share buyback plan on Friday, November 3rd that allows the company to buyback $50.00 million in outstanding shares. This buyback authorization allows the business services provider to purchase shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.
A number of large investors have recently bought and sold shares of HMSY. Bank of New York Mellon Corp raised its holdings in HMS by 75.0% during the fourth quarter. Bank of New York Mellon Corp now owns 3,016,623 shares of the business services provider’s stock valued at $51,132,000 after acquiring an additional 1,292,855 shares during the period. Kornitzer Capital Management Inc. KS bought a new stake in HMS during the third quarter valued at about $8,673,000. Millennium Management LLC bought a new stake in HMS during the fourth quarter valued at about $5,779,000. BlackRock Inc. raised its holdings in HMS by 3.0% during the fourth quarter. BlackRock Inc. now owns 10,812,870 shares of the business services provider’s stock valued at $183,279,000 after acquiring an additional 316,963 shares during the period. Finally, HCSF Management LLC bought a new stake in HMS during the fourth quarter valued at about $5,085,000. 94.24% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “HMS (HMSY) Stock Rating Lowered by Zacks Investment Research” was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://ledgergazette.com/2018/02/18/hms-hmsy-stock-rating-lowered-by-zacks-investment-research.html.
HMS Holdings Corp. is a holding company. The Company, through its subsidiaries, operates in the United States healthcare insurance benefit cost containment marketplace. It provides coordination of benefits services to government, and private healthcare payers and sponsors. Its payment integrity services ensure that healthcare claims billed are accurate and appropriate.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.